Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
Hiesse
C
C
Department of Nephrology, Bicêtre Hospital, University Paris-Sud, France.
Rousseau
P
P
Kriaa
F
F
Larue
J R
JR
Charpentier
B
B
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine